Biohaven Pharmaceutical Holding Co Ltd (BHVN)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Vladimir Coric
Employees:
930
234 CHURCH STREET, SUITE 304, NEW HAVEN, CT 06510
203-404-0410

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Biohaven Pharmaceutical Holding Company Ltd. develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. The company also offers Troriluzole for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases.

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 1.561 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-6.21
Price to Revenue12.0414 Debt to Equity-0.9496 EBITDA-725.395 Million
Price to Book Value0.0 Operating Margin-74.4354 Enterprise Value10.559 Billion
Current Ratio1.748 EPS Growth-0.025 Quick Ratio1.348
1 Yr BETA 11.0474 52-week High/Low 152.56 / 79.01 Profit Margin-108.2597
Operating Cash Flow Growth31.2704 Altman Z-Score-1.0685 Free Cash Flow to Firm -342.44 Million

Are you looking for this stock instead?

View SEC Filings from BHVN instead.

Biohaven Pharmaceutical Holding Co Ltd YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding BHVN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BHVN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

Events (8k)

  • 8-K: filed on 2022-10-03:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-29:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-27:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-23:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-23:
    Item 8.01: Other Events
  • 8-K: filed on 2022-09-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-19:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-28:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-11:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    BIOHAVEN LTD BHVN 2023-01-13 22:15:03 UTC 3.3949 0.9251 150000
    BIOHAVEN LTD BHVN 2023-01-13 21:45:04 UTC 3.3949 0.9251 150000
    BIOHAVEN LTD BHVN 2023-01-13 21:15:04 UTC 3.3949 0.9251 150000
    BIOHAVEN LTD BHVN 2023-01-13 20:45:03 UTC 3.3949 0.9251 150000
    BIOHAVEN LTD BHVN 2023-01-13 20:15:03 UTC 3.3949 0.9251 150000
    BIOHAVEN LTD BHVN 2023-01-13 19:45:03 UTC 3.3949 0.9251 150000
    BIOHAVEN LTD BHVN 2023-01-13 19:15:04 UTC 3.3949 0.9251 150000
    BIOHAVEN LTD BHVN 2023-01-13 18:45:03 UTC 3.3949 0.9251 150000
    BIOHAVEN LTD BHVN 2023-01-13 18:15:04 UTC 3.3949 0.9251 150000
    BIOHAVEN LTD BHVN 2023-01-13 17:45:03 UTC 3.3949 0.9251 150000
    BIOHAVEN LTD BHVN 2023-01-13 17:15:03 UTC 3.3949 0.9251 150000
    BIOHAVEN LTD BHVN 2023-01-13 16:45:03 UTC 3.3987 0.9213 150000
    BIOHAVEN LTD BHVN 2023-01-13 16:15:04 UTC 3.3987 0.9213 150000
    BIOHAVEN LTD BHVN 2023-01-13 15:45:03 UTC 3.3987 0.9213 200000
    BIOHAVEN LTD BHVN 2023-01-13 15:15:03 UTC 3.3987 0.9213 200000
    BIOHAVEN LTD BHVN 2023-01-13 14:45:04 UTC 3.3987 0.9213 200000
    BIOHAVEN LTD BHVN 2023-01-13 14:15:03 UTC 3.3987 0.9213 150000
    BIOHAVEN LTD BHVN 2023-01-13 13:45:03 UTC 3.4128 0.9072 150000
    BIOHAVEN LTD BHVN 2023-01-13 13:15:03 UTC 3.4128 0.9072 150000
    BIOHAVEN LTD BHVN 2023-01-13 12:45:03 UTC 3.4128 0.9072 150000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Trust for Professional Managers- Convergence Market Neutral Fund BHVN -1056.0 shares, $-66939.84 2020-08-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund BHVN -31.0 shares, $-1054.93 2020-03-31 N-PORT
    FundVantage Trust- Gotham Master Neutral Fund BHVN -21.0 shares, $-1365.21 2020-09-30 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund BHVN -1.0 shares, $-34.03 2020-03-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund BHVN -1575.0 shares, $-107651.25 2021-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments